Ataxia-telangiectasia (A-T) is a rare disorder caused by genetic defects of A-T mutated (ATM) kinase, a key regulator of stress response, and characterized by neurodegeneration, immunodeficiency, and high incidence of cancer. Here we investigated NK cells in a mouse model of A-T (Atm− /− ) showing that they are strongly impaired at killing tumor cells due to a block of early signaling events. On the other hand, in Atm− /− littermates with thymic lymphoma NK cell cytotoxicity is enhanced as compared with ATM-proficient mice, possibly via tumor- produced TNF-α. Results also suggest that expansion of exhausted NKG2D+ NK cells in Atm− /− mice is driven by low-level expression of stress-inducible NKG2D ligands, whereas development of thymoma expressing the high- affinity MULT1 ligand is associated with NKG2D down-regulation on NK cells. These results expand our understanding of immunodeficiency in A-T and encourage exploring NK cell biology in A-T patients in the attempt to identify cancer predictive biomarkers and novel therapeutic targets.
Absence of ATM leads to altered NK cell function in mice
Alessandro Giovinazzo;Daniela Marazziti;Manuela Pellegrini;
2024
Abstract
Ataxia-telangiectasia (A-T) is a rare disorder caused by genetic defects of A-T mutated (ATM) kinase, a key regulator of stress response, and characterized by neurodegeneration, immunodeficiency, and high incidence of cancer. Here we investigated NK cells in a mouse model of A-T (Atm− /− ) showing that they are strongly impaired at killing tumor cells due to a block of early signaling events. On the other hand, in Atm− /− littermates with thymic lymphoma NK cell cytotoxicity is enhanced as compared with ATM-proficient mice, possibly via tumor- produced TNF-α. Results also suggest that expansion of exhausted NKG2D+ NK cells in Atm− /− mice is driven by low-level expression of stress-inducible NKG2D ligands, whereas development of thymoma expressing the high- affinity MULT1 ligand is associated with NKG2D down-regulation on NK cells. These results expand our understanding of immunodeficiency in A-T and encourage exploring NK cell biology in A-T patients in the attempt to identify cancer predictive biomarkers and novel therapeutic targets.File | Dimensione | Formato | |
---|---|---|---|
1-s2.0-S1521661624003425-main.pdf
solo utenti autorizzati
Tipologia:
Versione Editoriale (PDF)
Licenza:
NON PUBBLICO - Accesso privato/ristretto
Dimensione
5.77 MB
Formato
Adobe PDF
|
5.77 MB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.